211 related articles for article (PubMed ID: 31242385)
1. Novel
Hanaoka H; Ohshima Y; Yamaguchi A; Suzuki H; Ishioka NS; Higuchi T; Arano Y; Tsushima Y
Mol Pharm; 2019 Aug; 16(8):3609-3616. PubMed ID: 31242385
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of bladder cancer using
Mahendra I; Hanaoka H; Yamaguchi A; Amartuvshin T; Tsushima Y
Ann Nucl Med; 2020 May; 34(5):329-336. PubMed ID: 32144655
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
[TBL] [Abstract][Full Text] [Related]
4. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
5. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
[TBL] [Abstract][Full Text] [Related]
6. Development of a Widely Usable Amino Acid Tracer: ⁷⁶Br-α-Methyl-Phenylalanine for Tumor PET Imaging.
Hanaoka H; Ohshima Y; Suzuki Y; Yamaguchi A; Watanabe S; Uehara T; Nagamori S; Kanai Y; Ishioka NS; Tsushima Y; Endo K; Arano Y
J Nucl Med; 2015 May; 56(5):791-7. PubMed ID: 25814518
[TBL] [Abstract][Full Text] [Related]
7. Transport of 3-fluoro-L-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [(18)F]FAMT positron emission tomography.
Wei L; Tominaga H; Ohgaki R; Wiriyasermkul P; Hagiwara K; Okuda S; Kaira K; Kato Y; Oriuchi N; Nagamori S; Kanai Y
J Pharmacol Sci; 2016 Feb; 130(2):101-9. PubMed ID: 26887331
[TBL] [Abstract][Full Text] [Related]
8.
Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
[TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of 3-[(76)Br]bromo-α-methyl-L-tyrosine, a novel tyrosine analog for positron emission tomography imaging of tumors.
Ohshima Y; Hanaoka H; Watanabe S; Sugo Y; Watanabe S; Tominaga H; Oriuchi N; Endo K; Ishioka NS
Nucl Med Biol; 2011 Aug; 38(6):857-65. PubMed ID: 21843782
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and biological evaluation of N-(2-[
Tang C; Nie D; Tang G; Gao S; Liu S; Wen F; Tang X
Nucl Med Biol; 2017 Jul; 50():39-46. PubMed ID: 28456080
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[
Ohshima Y; Suzuki H; Hanaoka H; Sasaki I; Watanabe S; Haba H; Arano Y; Tsushima Y; Ishioka NS
Nucl Med Biol; 2020; 90-91():15-22. PubMed ID: 32916470
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the accumulation level of 3-[
Kanai A; Hanaoka H; Yamaguchi A; Mahendra I; Palangka C; Ohshima Y; Higuchi T; Tsushima Y
Nucl Med Biol; 2022; 104-105():47-52. PubMed ID: 34896813
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
14. Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.
Suzuki S; Kaira K; Ohshima Y; Ishioka NS; Sohda M; Yokobori T; Miyazaki T; Oriuchi N; Tominaga H; Kanai Y; Tsukamoto N; Asao T; Tsushima Y; Higuchi T; Oyama T; Kuwano H
Br J Cancer; 2014 Apr; 110(8):1985-91. PubMed ID: 24667647
[TBL] [Abstract][Full Text] [Related]
15. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents.
Wang L; Lieberman BP; Plössl K; Qu W; Kung HF
Nucl Med Biol; 2011 Apr; 38(3):301-12. PubMed ID: 21492778
[TBL] [Abstract][Full Text] [Related]
18. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
Krämer SD; Mu L; Müller A; Keller C; Kuznetsova OF; Schweinsberg C; Franck D; Müller C; Ross TL; Schibli R; Ametamey SM
J Nucl Med; 2012 Mar; 53(3):434-42. PubMed ID: 22331220
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
20. Selective synthesis of L-2-[
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Labelled Comp Radiopharm; 2020 Jun; 63(8):368-375. PubMed ID: 32221982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
